Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7
- PMID: 19299654
- DOI: 10.1182/blood-2008-12-195693
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7
Comment on
-
Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7.Blood. 2007 Aug 1;110(3):1080-2; author reply 1083. doi: 10.1182/blood-2007-03-080630. Blood. 2007. PMID: 17644749 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

